Equities

Chongqing Taiji Industry Group Co Ltd

600129:SHH

Chongqing Taiji Industry Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)24.93
  • Today's Change0.33 / 1.34%
  • Shares traded9.13m
  • 1 Year change-44.55%
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1,8182,2271,324
Total Receivables, Net2,5713,1682,290
Total Inventory2,6912,2682,280
Prepaid expenses242306272
Other current assets, total283404541
Total current assets7,6058,3726,706
Property, plant & equipment, net4,9044,8794,450
Goodwill, net00--
Intangibles, net1,4651,3111,369
Long term investments276283347
Note receivable - long term------
Other long term assets61--148
Total assets14,41214,92513,170
LIABILITIES
Accounts payable1,4911,6541,565
Accrued expenses1,8961,7811,044
Notes payable/short-term debt3,9203,8474,244
Current portion long-term debt/capital leases497556936
Other current liabilities, total1,7432,7891,209
Total current liabilities9,54810,6268,997
Total long term debt464684823
Total debt4,8815,0876,003
Deferred income tax164173
Minority interest124(131)(125)
Other liabilities, total638616675
Total liabilities10,79011,83610,443
SHAREHOLDERS EQUITY
Common stock557557557
Additional paid-in capital2,0722,1022,074
Retained earnings (accumulated deficit)1,130534188
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(137)(106)(93)
Total equity3,6223,0882,727
Total liabilities & shareholders' equity14,41214,92513,170
Total common shares outstanding557557557
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.